Literature DB >> 17587315

Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women.

M Manavi1, G Hudelist, A Fink-Retter, D Gschwantler-Kaulich, K Pischinger, K Czerwenka.   

Abstract

The human papillomavirus (HPV) plays an important role in the progression of cervical carcinoma. High-risk (HR) HPV types have been mainly identified in cytologic high-grade squamous intraepithelial lesions (HSILs) and histologic invasive carcinoma of the cervix. We examined cervical swabs of patients with abnormal Papanicolaou (Pap) smears, diagnosed as low-grade squamous intraepithelial lesions (LSILs) including atypical squamous cells of uncertain significance or HSILs. Low-risk (LR) HPV and HR-HPV types were identified by the Digene Hybrid Capture II test. Two-dimensional (2D) gel electrophoresis was used to specify the physical state of HPV DNA sequences. Expression of E6/E7 messenger RNA (mRNA) transcripts was analyzed by reverse transcriptase-polymerase chain reaction. Histopathologic results were correlated to the patients' physical status and HPV DNA mRNA transcripts. Pap smears with HPV infections of LR and HR types were correlated to the degree of squamous intraepithelial lesions (SILs). Comparing the physical states of HPV DNA sequences with the expression of HPV E6/E7 mRNA transcripts, all types were identified only as extrachromosomal in benign cervical smears, cervical intraepithelial neoplasia (CIN) I and II. HPV16 showed all physical states in CIN III/carcinoma in situ (CIS), whereas HPV18 only existed in mixed and integrated forms. HPV31/33/52b/58 appeared in all stages of lesions most commonly in extrachromosomal form; in integrated form, they were present only in CIN III/CIS. Although integration of some HR-HPV types is not always necessary for progression of SILs, the above-mentioned method is useful to analyze the physical state of HPV DNA sequences and predict the progression of SILs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587315     DOI: 10.1111/j.1525-1438.2007.01017.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  7 in total

1.  High risk HPV DNA subtypes and E6/E7 mRNA expression in a cohort of colposcopy patients from Northern Italy with high-grade histologically verified cervical lesions.

Authors:  Liverani Ca; Ciavattini A; Monti E; Puglia D; Mangano S; D I Giuseppe J; Zizzi A; Goteri G; Bolis G
Journal:  Am J Transl Res       Date:  2012-10-10       Impact factor: 4.060

2.  Human papillomavirus type 18 DNA load and 2-year cumulative diagnoses of cervical intraepithelial neoplasia grades 2-3.

Authors:  Long Fu Xi; Laura A Koutsky; Philip E Castle; Cosette M Wheeler; Denise A Galloway; Constance Mao; Jesse Ho; Nancy B Kiviat
Journal:  J Natl Cancer Inst       Date:  2009-01-27       Impact factor: 13.506

3.  RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus.

Authors:  Paola Cattani; Alessia Siddu; Sara D'Onghia; Simona Marchetti; Rosaria Santangelo; Valerio G Vellone; Gian Franco Zannoni; Giovanni Fadda
Journal:  J Clin Microbiol       Date:  2009-04-29       Impact factor: 5.948

4.  Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.

Authors:  Paola Cattani; Gian Franco Zannoni; Caterina Ricci; Sara D'Onghia; Ilaria Nausica Trivellizzi; Aldo Di Franco; Valerio G Vellone; Maria Durante; Giovanni Fadda; Giovanni Scambia; Giovanni Capelli; Rosa De Vincenzo
Journal:  J Clin Microbiol       Date:  2009-10-14       Impact factor: 5.948

5.  Analysis of human papillomavirus type 18 load and integration status from low-grade cervical lesion to invasive cervical cancer.

Authors:  Jo L K Cheung; Tak-Hong Cheung; Candy W Y Ng; Mei Y Yu; Martin C S Wong; Shing-Shun N Siu; So-Fan Yim; Paul K S Chan
Journal:  J Clin Microbiol       Date:  2008-11-26       Impact factor: 5.948

6.  Long (27-nucleotides) small inhibitory RNAs targeting E6 protein eradicate effectively the cervical cancer cells harboring human papilloma virus.

Authors:  Jun Sik Cho; Shin-Wha Lee; Yong-Man Kim; Dongho Kim; Dae-Yeon Kim; Young-Tak Kim
Journal:  Obstet Gynecol Sci       Date:  2015-05-19

7.  HPV-Based Screening, Triage, Treatment, and Followup Strategies in the Management of Cervical Intraepithelial Neoplasia.

Authors:  Oscar Peralta-Zaragoza; Jessica Deas; Claudia Gómez-Cerón; Wendy Argelia García-Suastegui; Geny Del Socorro Fierros-Zárate; Nadia Judith Jacobo-Herrera
Journal:  Obstet Gynecol Int       Date:  2013-04-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.